<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-3UHBNLU2</identifier><date>2006</date><creator>Calado, Federico</creator><creator>Kos, Mitja</creator><relation>documents/znanstveni_clanki/farmacevtski_vestnik/html/urn_nbn_si_doc-3uhbnlu2.html</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/pdf/urn_nbn_si_doc-3uhbnlu2.pdf</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/txt/urn_nbn_si_doc-3uhbnlu2.txt</relation><format format_type="issue">4</format><format format_type="volume">57</format><format format_type="main">6 strani</format><format format_type="type">article</format><format format_type="extent">str. 268-273</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">231520000</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-3UHBNLU2</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antidepresivi</subject><subject language_type_id="slv">farmakoekonomika</subject><title>Pharmacoeconomic perspective on depressive disorder treatment with antidepressants</title></Record>